We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+5.88%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$21.3B
AUM Growth
-$547M
Cap. Flow
-$8.07B
Cap. Flow %
-37.88%
Top 10 Hldgs %
16.57%
Holding
1,618
New
335
Increased
76
Reduced
310
Closed
386

Sector Composition

Rank Sector Weight
1 Technology 13.17%
2 Financials 12.22%
3 Healthcare 8.73%
4 Consumer Discretionary 5.35%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCOBW
976
DELISTED
ScION Tech Growth II Warrants
SCOBW
$540 ﹤0.01%
33,333
BLUA.WS
977
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$530 ﹤0.01%
33,333
CEROW
978
DELISTED
CERo Therapeutics Warrants
CEROW
$491 ﹤0.01%
12,500
STRE.WS
979
DELISTED
Supernova Partners Acquisition Company III, Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
STRE.WS
$460 ﹤0.01%
+20,000
New +$1.13K
TRONW
980
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
$417 ﹤0.01%
41,666
PTOCW
981
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
$402 ﹤0.01%
+236,666
New +$7.71K
FRONW
982
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
$394 ﹤0.01%
25,000
AILEW
983
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$250 ﹤0.01%
50,000
TZPSW
984
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$223 ﹤0.01%
33,333
DRAYW
985
DELISTED
Macondray Capital Acquisition Corp. I Warrant
DRAYW
$184 ﹤0.01%
283,483
KRNLW
986
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$138 ﹤0.01%
25,060
ACQRW
987
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$122 ﹤0.01%
20,000
CPARW
988
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$102 ﹤0.01%
60,000
THACW
989
DELISTED
Thrive Acquisition Corporation Warrant
THACW
$93 ﹤0.01%
12,500
LVACW
990
DELISTED
LAVA Medtech Acquisition Corp. Warrants
LVACW
$64 ﹤0.01%
12,500
ABNB icon
991
Airbnb
ABNB
$90.8B
-4,261
Closed -$448K
ACHC icon
992
Acadia Healthcare
ACHC
$2.52B
-37,364
Closed -$2.92M
AEON icon
993
AEON Biopharma
AEON
$10.7M
-3,472
Closed -$2.46M
AGL icon
994
Agilon Health
AGL
$1.55B
-599
Closed -$351K
ALGN icon
995
Align Technology
ALGN
$12.9B
-43,438
Closed -$9M
ALHC icon
996
Alignment Healthcare
ALHC
$3.78B
-122,962
Closed -$1.46M
ALKT icon
997
Alkami Technology
ALKT
$1.96B
-109,836
Closed -$1.65M
ALTI icon
998
AlTi Global
ALTI
$395M
-210,000
Closed -$2.08M
AMZN icon
999
PUT
Amazon
AMZN
$2.44T
-70,000
Closed -$7.91M
AREC icon
1000
American Resources Corp
AREC
$183M
-175,887
Closed -$470K

Similar funds

Calamos Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Calamos Advisors held 1,618 positions worth $21.3B, down 2.5% from $21.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Calamos Advisors withdrew a net $8.07B in Q4 2022, closing 386 positions and reducing 310 holdings. Its most notable exit was DTE Energy Company 2019 Corporate Units, an estimated $51.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Vanguard S&P 500 ETF worth $471M.

  • Calamos Advisors's largest Q4 2022 buy was Vanguard S&P 500 ETF: 1,340,747 shares worth $471M.
  • Calamos Advisors added most to T-Mobile US in Q4 2022, an estimated $24.1M increase.
  • Calamos Advisors's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • Calamos Advisors fully exited DTE Energy Company 2019 Corporate Units in Q4 2022, selling an estimated $51.3M.
  • Calamos Advisors's ten largest holdings make up 17% of its $21.3B portfolio in Q4 2022.
  • Calamos Advisors opened 335 new positions and closed 386 in Q4 2022.
  • Calamos Advisors's portfolio value fell 2.5% quarter-over-quarter to $21.3B.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.